Literature DB >> 8012904

Interaction of mutants of Xenorhabdus nematophilus (Enterobacteriaceae) with antibacterial systems of Galleria mellonella larvae (Insecta: Pyralidae).

G B Dunphy1.   

Abstract

Xenorhabdus nematophilus mutants that took longer to kill insects than did the wild type were used to determine the relationship of the physicochemical properties and outer membrane composition to bacterial interaction with the antibacterial systems of Galleria mellonella larvae and to bacterial virulence. Insect serum slowed the growth of the wild-type and mutant bacteria. This was attributed to increased spheroplast formation for the mutants. Spheroplast formation was associated with an increased sensitivity to insect lysozyme and a reduction in overall bacterial cationic charge. Increasing bacterial hydrophobicity was correlated with both increased bacterial attachment to the insect's haemocytes and the accelerated removal of the bacteria from the haemolymph. Attachment of the mutants to the insect haemocytes also increased as the bacterial lipopolysaccharide content increased, the level of prophenoloxidase activation increased, and cationic charge declined. Bacterial emergence into the haemolymph occurred in parallel with haemocyte damage but neither the total lipopolysaccharide levels in the bacteria nor the rate of bacterial emergence were associated with virulence. The rate of lipopolysaccharide release into the haemolymph influenced the rate of haemocyte damage. The contribution of outer membrane proteins to lipopolysaccharide release, bacterial adhesion to haemocytes, and virulence is discussed. Virulence reflects bacterial tolerance to the host's antibacterial defences, favouring an increase in bacteria and toxic lipopolysaccharides.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012904     DOI: 10.1139/m94-028

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  7 in total

1.  The PhoP-PhoQ two-component regulatory system of Photorhabdus luminescens is essential for virulence in insects.

Authors:  Sylviane Derzelle; Evelyne Turlin; Eric Duchaud; Sylvie Pages; Frank Kunst; Alain Givaudan; Antoine Danchin
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

Review 2.  Molecular biology of the symbiotic-pathogenic bacteria Xenorhabdus spp. and Photorhabdus spp.

Authors:  S Forst; K Nealson
Journal:  Microbiol Rev       Date:  1996-03

3.  Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis.

Authors:  Eleftherios Mylonakis; Roberto Moreno; Joseph B El Khoury; Alexander Idnurm; Joseph Heitman; Stephen B Calderwood; Frederick M Ausubel; Andrew Diener
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

4.  Purification and characterization of an extracellular protease from Xenorhabdus nematophila involved in insect immunosuppression.

Authors:  C Caldas; A Cherqui; A Pereira; N Simões
Journal:  Appl Environ Microbiol       Date:  2002-03       Impact factor: 4.792

5.  Characterization and environmental regulation of outer membrane proteins in Xenorhabdus nematophilus.

Authors:  G B Leisman; J Waukau; S A Forst
Journal:  Appl Environ Microbiol       Date:  1995-01       Impact factor: 4.792

6.  Variations of Indole Metabolites and NRPS-PKS Loci in Two Different Virulent Strains of Xenorhabdus hominickii.

Authors:  Md Mahi Imam Mollah; Miltan Chandra Roy; Doo-Yeol Choi; Md Ariful Hasan; Md Abdullah Al Baki; Hyun-Suk Yeom; Yonggyun Kim
Journal:  Front Microbiol       Date:  2020-11-24       Impact factor: 5.640

7.  The insect pathogenic bacterium Xenorhabdus innexi has attenuated virulence in multiple insect model hosts yet encodes a potent mosquitocidal toxin.

Authors:  Il-Hwan Kim; Sudarshan K Aryal; Dariush T Aghai; Ángel M Casanova-Torres; Kai Hillman; Michael P Kozuch; Erin J Mans; Terra J Mauer; Jean-Claude Ogier; Jerald C Ensign; Sophie Gaudriault; Walter G Goodman; Heidi Goodrich-Blair; Adler R Dillman
Journal:  BMC Genomics       Date:  2017-12-01       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.